Assignee
SHANGHAI JEMINCARE PHARMACEUTICALS CO LTD
CN·7 granted patents·19 pending applications·11 citations·filing 2019–2025
Top patents by PatentIndex Score
26 records- 0192US11767312B2Phthalazinone compound, and preparation method therefor and medical use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2023·Granted Sep 26, 2023·6 cites·14 claims
- 0285US12122787B2Fused pyridone compound, and preparation method therefor and use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2023·Granted Oct 22, 2024·1 cites·13 claims
- 0382US12234223B2Phthalazinone compound, and preparation method therefor and medical use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2024·Granted Feb 25, 2025·0 cites·30 claims
- 0479US12195457B2Aromatic ring derivative as immunoregulation and preparation method and application of aromatic ring derivativeSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2019·Granted Jan 14, 2025·2 cites·16 claims
- 0579US11401295B2Cyclic dinucleotide compound and uses thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2019·Granted Aug 2, 2022·2 cites·20 claims
- 0677US2025376463A1Protein degradation agent compound preparation method and applicationSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 0774US2023131252A1Phthalazinone compound, and preparation method therefor and medical use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0857US2025051321A1Tricyclic derivative and preparation method therefor and application thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0957US2024208908A1Crystal form of pyridine nitrogen oxide compound and use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1056US12441706B2Protein degradation agent compound preparation method and applicationSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2020·Granted Oct 14, 2025·0 cites·31 claims
- 1155US2024228446A1Preparation method for bicyclic compound and application as antifungal agentSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1255US2024082406A1Benzoheterocycle substituted tetrahydroisoquinoline compoundSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1354US2025051281A1Crystalline form of aromatic ring derivative, and preparation method therefor and application thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1454US2024101568A1Novel benzazepine spiro derivativeSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1552US2024158367A1Tricyclic compound as hif2-alpha inhibitor, preparation method therefor and application thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1651US2024124576A1Preparation of siglec-15 binding protein and use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1750US2025277038A1Anti-pd-l1 antibody and use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1850US2024117034A1GARP Protein Antibody and Use ThereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1950US2022298174A1Tetracyclic compound, preparation method therefor and use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 2049US2022267364A1Heterocyclic amide compound, preparation method therefor and use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 2148US2024141069A1Anti-masp-2 antibody and use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2248US2024287168A1Anti-vegf antibody and use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2348US2025223303A1Tricyclic boronic acid derivative, and preparation method therefor and application thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2448US2022389029A1Fused pyridone compound, and preparation method therefor and use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 2546US2023250191A1Anti-ige engineered antibody and application thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 2645US11518766B2Tricyclic compound, preparation method therefor and use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2020·Granted Dec 6, 2022·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI JEMINCARE PHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →